Axonics Modulation Technologies Inc
Axonics, Inc., a medical technology company, engages in the development and commercialization of novel products for the treatment of bladder and bowel dysfunction. Its sacral neuromodulation (SNM) systems are used to treat patients with overactive bladder (OAB), including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence (FI) and non-obstructive urinary retent… Read more
Axonics Modulation Technologies Inc - Asset Resilience Ratio
Axonics Modulation Technologies Inc (AXNX) has an Asset Resilience Ratio of 13.66% as of September 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2023)
This chart shows how Axonics Modulation Technologies Inc's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Axonics Modulation Technologies Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $105.77 Million | 13.66% |
| Total Liquid Assets | $105.77 Million | 13.66% |
Asset Resilience Insights
- Moderate Liquidity: Axonics Modulation Technologies Inc has 13.66% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Axonics Modulation Technologies Inc Industry Peers by Asset Resilience Ratio
Compare Axonics Modulation Technologies Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
FluroTech Ltd
OTCQB:FLURF |
Medical Devices | 0.00% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 0.50% |
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022 |
Medical Devices | 0.01% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.26% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 7.79% |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932 |
Medical Devices | 6.64% |
|
Shinhung
KO:004080 |
Medical Devices | 4.17% |
|
UMediC Group Berhad
KLSE:0256 |
Medical Devices | 1.48% |
Annual Asset Resilience Ratio for Axonics Modulation Technologies Inc (2016–2023)
The table below shows the annual Asset Resilience Ratio data for Axonics Modulation Technologies Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 33.36% | $240.15 Million | $719.92 Million | +15.41pp |
| 2022-12-31 | 17.95% | $118.36 Million | $659.35 Million | -- |
| 2021-12-31 | 0.00% | $0.00 | $547.95 Million | -- |
| 2020-12-31 | 0.00% | $0.00 | $342.21 Million | -- |
| 2019-12-31 | 5.73% | $12.59 Million | $219.82 Million | -28.72pp |
| 2018-12-31 | 34.45% | $59.22 Million | $171.91 Million | -- |
| 2017-12-31 | 0.00% | $0.00 | $29.41 Million | -- |
| 2016-12-31 | 0.00% | $0.00 | $10.86 Million | -- |